LivaNova (LIVN) Return on Capital Employed Growth (3y) (2019 - 2026)
LivaNova (LIVN) Return on Capital Employed Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | 1,517.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,517.00 |
| Dec 31, 2025 | 1,516.00 |
| Sep 30, 2025 | 1,469.00 |
| Jun 30, 2025 | 638.00 |
| Mar 31, 2025 | 829.00 |
| Dec 31, 2024 | 613.00 |
| Sep 30, 2024 | 1,702.00 |
| Jun 30, 2024 | 1,576.00 |
| Mar 31, 2024 | 1,100.00 |
| Dec 31, 2023 | 938.00 |
| Sep 30, 2023 | 921.00 |
| Jun 30, 2023 | 106.00 |
| Mar 31, 2023 | 333.00 |
| Dec 31, 2022 | 474.00 |
| Sep 30, 2022 | 1,105.00 |
| Jun 30, 2022 | 2,042.00 |
| Mar 31, 2022 | 1,513.00 |
| Dec 31, 2021 | 1,185.00 |
| Sep 30, 2021 | -1,882.00 |
| Jun 30, 2021 | -2,140.00 |